MedLumics Proprietary Technology to be presented at 26th Annual International AF Symposium
- MedLumics is developing a unique real-time, optically-guided ablation catheter to improve treatment of Atrial Fibrillation by RadioFrequency Ablation and Pulsed Field Ablation
- Presentation on Direct Lesion Assessment using Photonics during AF Ablation
News provided by
Share this article
Share this article
MADRID, Jan. 28, 2021 /PRNewswire/ MedLumics, a privately held medical technology company developing AblaView®, an optically-guided RadioFrequency (RF) catheter ablation system for the treatment of Atrial Fibrillation (AF), announced today the first public communication on its technology using photonics during AF ablation at the upcoming 26
Renowned cardiologist Dr Atul Verma, FHRS, FRCPC, Director of Arrhythmia Services at Southlake Regional Health Care Centre in Newmarket, Ontario, Canada will present during